Table 3. | Colorimetric analysis |
| Patients | ΔE | P-value* | |
|---|---|---|---|
| Mean (SD) | |||
| Healthy | 1.05 (0.85)A | < 0.001 | |
| Cancer | Non-operated site | 2.94 (2.2)B | < 0.001 |
| Operated site | 5.71 (4)C | < 0.001 | |
*The data were not normally distributed (Shapiro-Wilk test, P < 0.05).
|
Table 3. | Colorimetric analysis |
| Patients | ΔE | P-value* | |
|---|---|---|---|
| Mean (SD) | |||
| Healthy | 1.05 (0.85)A | < 0.001 | |
| Cancer | Non-operated site | 2.94 (2.2)B | < 0.001 |
| Operated site | 5.71 (4)C | < 0.001 | |
*The data were not normally distributed (Shapiro-Wilk test, P < 0.05).
|